Identification of interleukin-11 as a comorbid risk factor for prostate cancer and Alzheimer's disease using integrated bioinformatics and machine learning.
Overview
- School of Medicine, Southeast University, Nanjing, China
- Department of Pathology, Zhongda Hospital, Southeast University, Nanjing, China
- Department of Neurology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School of Nanjing Medical University, Suzhou, China
- Department of Urology, Zhongda Hospital, Southeast University, Nanjing, China
Abstract
Background: Prostate cancer (PCa) and Alzheimer’s disease (AD) are age-related disorders with a complex epidemiological association and limited therapeutic options. Identifying shared molecular drivers may reveal new treatment targets.
Objective: To identify common transcriptomic signatures between PCa and AD and validate the role of interleukin-11 (IL11) as a functional comorbidity factor.
Methods: Multi-cohort transcriptomic datasets (GSE48350, GSE5281 and GSE28146 for AD; TCGA-PRAD, DKFZ2018 and MSKCC for PCa) were analyzed. Differential expression analysis and weighted gene co-expression network analysis (WGCNA) were performed, followed by a two-tier machine learning pipeline (Random Forest and LASSO Cox regression) to screen overlapping genes. Immune infiltration was evaluated by CIBERSORT and single-cell transcriptomics for PCa. The functional role of IL11 was assessed in RM-1 murine and DU145 human PCa cells using colony formation, wound healing, Transwell assays, and immunocompetent C57BL/
Results: A total of 455 shared candidate genes were identified, and a 10-gene signature (NDRG4, ISG15, IL11, ENO2, DYNC1I1, DNASE1, ATP6V1G2, ATCAY, ANLN, AGAP9) was established. The risk score effectively stratified PCa patients with poor progression-free interval (log-rank P < 0.001; AUC for 1-,3-,5-year = 0.78,0.73,0.70), validated in two external cohorts (DKFZ2018, MSKCC). IL11 was the top candidate and was significantly upregulated in both diseases. High IL11 expression correlated with an immunosuppressive microenvironment, characterized by increased M2 macrophages and regulatory T cells, and with higher tumor mutation burden. Single-cell analysis localized IL11 to a subset of cancer-associated fibroblasts. In vitro, IL11 treatment enhanced PCa cell proliferation, migration, and invasion. In vivo, intraperitoneal IL11 accelerated PCa tumor growth in mice. In the MWM test, IL11-treated mice exhibited significantly longer escape latencies and fewer platform crossings, which were accompanied by increased hippocampal Aβ deposition, suggesting that IL11 induced cognitive dysfunction. Cross-sectional cohort analyses further linked higher serum IL11 to reduced CSF Aβ42 and elevated p-tau181.
Conclusion: IL11 acts as a shared risk factor related to PCa progression and cognitive decline in AD, representing a convergent molecular pathway and a potential therapeutic target for both age-related diseases.
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GSE5281, at NCBI GEO; found in the text, “Data acquisition and preprocessing”
Other data links
- ncbi.nlm.nih.gov/
geo , NCBI; found in the text, “Data acquisition and preprocessing”
Data availability statement
The original contributions presented in the study are included in the article/
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 2, 28 September 2026
- Funding: added National Natural Science Foundation of China; Southeast University
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, pages, dates, 15 authors, 5 keywords, 16 MeSH terms, 55 references, 1 RRID.
Cite
This paper
Wang, M., Qian, Y., Huang, E., Chu, C., Gao, T., Chen, S., Zhao, N., Luo, C., Liu, Y., Zheng, X., Hu, H., Han, B., Chen, M., Mao, W., & Li, W. (2026). Identification of interleukin-11 as a comorbid risk factor for prostate cancer and Alzheimer's disease using integrated bioinformatics and machine learning. Frontiers in immunology, 17, 1911726. https://
BibTeX
@article{wang2026identif
author = {Wang, Mengxue and Qian, Yanrong and Huang, Enyao and Chu, Chunyan and Gao, Tian and Chen, Shengrong and Zhao, Na and Luo, Caichen and Liu, Yifan and Zheng, Xiejunhao and Hu, Haowen and Han, Bowen and Chen, Ming and Mao, Weipu and Li, Wenchao},
title = {{Identification of interleukin-11 as a comorbid risk factor for prostate cancer and Alzheimer's disease using integrated bioinformatics and machine learning}},
journal = {Frontiers in immunology},
year = {2026},
month = aug,
volume = {17},
pages = {1911726},
publisher = {Frontiers Media SA},
issn = {1664-3224},
doi = {10.3389/
url = {https://
pmid = {42694488},
pmcid = {PMC13538895}
}
RIS
TY - JOUR
AU - Wang, Mengxue
AU - Qian, Yanrong
AU - Huang, Enyao
AU - Chu, Chunyan
AU - Gao, Tian
AU - Chen, Shengrong
AU - Zhao, Na
AU - Luo, Caichen
AU - Liu, Yifan
AU - Zheng, Xiejunhao
AU - Hu, Haowen
AU - Han, Bowen
AU - Chen, Ming
AU - Mao, Weipu
AU - Li, Wenchao
TI - Identification of interleukin-11 as a comorbid risk factor for prostate cancer and Alzheimer's disease using integrated bioinformatics and machine learning
T2 - Frontiers in immunology
J2 - Front Immunol
PY - 2026
DA - 2026/
VL - 17
SP - 1911726
SN - 1664-3224
PB - Frontiers Media SA
DO - 10.3389/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.3389/
"type": "article-journal",
"title": "Identification of interleukin-11 as a comorbid risk factor for prostate cancer and Alzheimer's disease using integrated bioinformatics and machine learning",
"container-title": "Frontiers in immunology",
"author": [
{
"family": "Wang",
"given": "Mengxue"
},
{
"family": "Qian",
"given": "Yanrong"
},
{
"family": "Huang",
"given": "Enyao"
},
{
"family": "Chu",
"given": "Chunyan"
},
{
"family": "Gao",
"given": "Tian"
},
{
"family": "Chen",
"given": "Shengrong"
},
{
"family": "Zhao",
"given": "Na"
},
{
"family": "Luo",
"given": "Caichen"
},
{
"family": "Liu",
"given": "Yifan"
},
{
"family": "Zheng",
"given": "Xiejunhao"
},
{
"family": "Hu",
"given": "Haowen"
},
{
"family": "Han",
"given": "Bowen"
},
{
"family": "Chen",
"given": "Ming"
},
{
"family": "Mao",
"given": "Weipu"
},
{
"family": "Li",
"given": "Wenchao"
}
],
"container-title-short":
"volume": "17",
"page": "1911726",
"DOI": "10.3389/
"PMID": "42694488",
"PMCID": "PMC13538895",
"ISSN": "1664-3224",
"publisher": "Frontiers Media SA",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
8,
20
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.3389/fendo.2024.1345498
- Transcriptomic analysis reveals sex-specific patterns in the hippocampus in Alzheimer's disease.Journal: Frontiers in endocrinologyIn common: NCBI GEO GSE5281, Alzheimer's / dementia, genetics / omics, 2 references
- [2] doi:10.1186/s12920-025-02219-z
- Exploration and validation of the immune-related genes signatures and potential molecular mechanisms shared between Alzheimer's disease (AD) and Parkinson's disease (PD).Journal: BMC medical genomicsIn common: NCBI GEO GSE5281, Alzheimer's / dementia, genetics / omics, mouse, 2 references
- [3] doi:10.4062/biomolther.2025.150
- Microglial PLXDC2 Modulates Aβ Phagocytosis and Inflammatory Responses.Journal: Biomolecules & therapeuticsIn common: NCBI GEO GSE5281, Alzheimer's / dementia, genetics / omics, 2 references
- [4] doi:10.1111/acel.14044
- Integrative multi-omics analysis reveals the critical role of the PBXIP1 gene in Alzheimer's disease.Journal: Aging cellIn common: NCBI GEO GSE5281, Alzheimer's / dementia, genetics / omics, 2 references
- [5] doi:10.3389/fnagi.2025.1617611 [code]
- Estimating progression of Alzheimer's disease with extracellular vesicle-related multi-omics risk models.Journal: Frontiers in aging neuroscienceIn common: NCBI GEO GSE5281, Alzheimer's / dementia, genetics / omics, 2 references
- [6] doi:10.3389/fnagi.2023.1105690
- lncRNA-associated ceRNA network revealing the potential regulatory roles of ferroptosis and immune infiltration in Alzheimer's disease.Journal: Frontiers in aging neuroscienceIn common: NCBI GEO GSE5281, Alzheimer's / dementia, 2 references
- [7] doi:10.1186/s12974-025-03683-1
- IL-27, a metabolic regulator secreted by astrocytes in response to GLP-1RA OHP2, modulates microglial reprogramming in Alzheimer's disease by regulating cGAS lactylation.Journal: Journal of neuroinflammationIn common: NCBI GEO GSE5281, Alzheimer's / dementia, mouse, 1 reference
- [8] doi:10.1038/s41380-025-03181-z
- Histone demethylase PHF2 regulates inflammatory genes in Alzheimer's disease.Journal: Molecular psychiatryIn common: Alzheimer's / dementia, mouse, 3 references
- [9] doi:10.3390/ijms24065651
- Shared Genes of <i>PPARG</
i> and <i>NOS2</ i> in Alzheimer's Disease and Ulcerative Colitis Drive Macrophages and Microglia Polarization: Evidence from Bioinformatics Analysis and Following Validation. Journal: International journal of molecular sciencesIn common: NCBI GEO GSE5281, Alzheimer's / dementia, 1 reference - [10] doi:10.3389/fchem.2025.1574702
- Neuraminidase as a novel therapeutic management strategy for Alzheimer's disease: evidenced through molecular docking, molecular dynamic simulation and gene expression analysis.Journal: Frontiers in chemistryIn common: NCBI GEO GSE5281, Alzheimer's / dementia, 1 reference
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
